Funded Tech Companies

Immune Pharmaceuticals

Operating out of Englewood Cliffs, Immune Pharmaceuticals has funding from Merlin BioMed Group.

Company Overview

Company Name
Immune Pharmaceuticals
Company Status
Publicly-held
Funding Rounds
Total Funding

Contact Information

Mailing Address
550 Sylvan Ave. 101
Englewood Cliffs, NJ 07632
USA
Email Address
Not Recorded

Company Background Information

Overview
Immune Pharmaceuticals Inc. (NASDAQ OMX First North Premier: IMNP; OTCQX: IMNP,) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer.
Profile
Immune Pharmaceuticals LinkedIn Company Profile
Social Media
Immune Pharmaceuticals Company Twitter Account
Company News
Immune Pharmaceuticals News
Facebook
Immune Pharmaceuticals on Facebook
YouTube
Immune Pharmaceuticals on YouTube
Last Transaction
3/31/2005

Financing History

Date
Type
Amount
Venture Equity
Unknown


Management Team

Title
Name
Email & Social
Chief Executive Officer
Elliot Maza
  Elliot Maza LinkedIn Profile  Elliot Maza Twitter Account  Elliot Maza News  Elliot Maza on Facebook
Chief Medical Officer
Tony Fiorino
  Tony Fiorino LinkedIn Profile  Tony Fiorino Twitter Account  Tony Fiorino News  Tony Fiorino on Facebook


Company Investors

  • Merlin BioMed Group

 

 

 

Browse more funded tech companies:

Immune Design | Immune-Onc Therapeutics

 

Share this article

 


About Our VC Funding Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary